The burden and impact of vertigo: Findings from the REVERT patient registry

Frontiers in Neurology

Volumn 4 OCT, Issue , 2013, Pages

  Benecke, Heike ^a   Agus, Sam ^b,d   Kuessner, Daniel ^b,e   Goodall, Gordon ^b,f   Strupp, Michael ^c  

^a ABBOTT GMBH AND CO KG   (Germany)

^b ABBOTT LABORATORIES   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Shire AG   (Switzerland)

^e BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

^f EDWARDS LIFESCIENCES   (United States)

Author keywords

Economic burden; Healthcare resource; Meniere's disease; Registry; Vertigo

Indexed keywords

ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BETAHISTINE; CALCIUM ANTAGONIST; GINKGO BILOBA EXTRACT; NEUROLEPTIC AGENT; PIRACETAM;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BENIGN PAROXYSMAL POSITIONAL VERTIGO; DISEASE SEVERITY; DIZZINESS; EMERGENCY HEALTH SERVICE; EMPLOYMENT STATUS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH SERVICE; HOMEOPATHY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENIERE DISEASE; OCCUPATIONAL HEALTH; PRESCRIPTION; PRIMARY MEDICAL CARE; PRODUCTIVITY; QUANTITATIVE ANALYSIS; VERTIGO; WORKING TIME; WORKLOAD;

EID: 84885350504     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00136     Document Type: Article

References (16)

1. Hanley K, O'Dowd T, Considine N. A systematic review of vertigo in primary care. Br J Gen Pract (2001) 51:666-71.
2. Kuo CH, Pang L, Chang R. Vertigo-part 1-assessment in general practice. Aust Fam Physician (2008) 37:341-7.
3. Strupp M, Brandt T. Diagnosis and treatment of vertigo and dizziness. Dtsch Arztebl Int (2008) 105:173-80. doi: 10.3238/arztebl.2008.0173.
4. Yardley L, Putman J. Quantitative analysis of factors contributing to handicap and distress in vertiginous patients: a questionnaire study. Clin Otolaryngol Allied Sci (1992) 17:231-6. doi:10.1111/j.1365-2273.1992.tb01833.x.
5. Skoien A, Wilhemsen K, Gjesdal S. Occupational disability caused by dizziness and vertigo: a register-based prospective study. Br J Gen Pract (2008) 58:619-23. doi:10.3399/bjgp08X330744.
6. Gopinath B, McMahon CM, Rochtchina E, Mitchell P. Dizziness and vertigo in an older population: the Blue Mountains prospective cross-sectional study. Clin Otolaryngol (2009) 34:552-6. doi:10.1111/j.1749-4486.2009.02025.x.
7. Yardley L, Owen N, Nazareth I, Luxon L. Prevalence and presentation of dizziness in a general practice community sample of working age people. Br J Gen Pract (1998) 48:1131-5.
8. Neuhauser H. Epidemiology of vertigo. Curr Opin Neurol (2007) 20:40-6. doi:10.1097/WCO.0b013e328013f432.
9. Neuhauser H, Radtke A, von Brevern M, Lezius F, Feldmann M, Lempert T. Burden of dizziness and vertigo in the community. Arch Intern Med (2008) 168:2118-24. doi:10.1001/archinte.168.19.2118.
10. Bjorne A, Agerberg G. Reduction in sick leave and costs to society of patients with Meniere's disease after treatment of temporomandibular and cervical spine disorders: a controlled six-year cost-benefit study. Cranio (2003) 21:136-43.
11. Cohen H, Ewell LR, Jenkins HA. Disability in Meniere's disease. Arch Otolaryngol Head Neck Surg (1995) 121:29-33. doi:10.1001/archotol.1995.01890010017004.
12. Agus S, Benecke H, Thum C, Strupp M. Clinical and demographic features of vertigo: findings from the REVERT registry. Front Neurol (2013) 10:48. doi:10.3389/fneur.2013.00048.
13. US Department of Health Education and Welfare. ECDEU Assessment Manual for Psychopharmacology-Revised (DHEW Publ No ADM 76-338). Rockville: Public Health Service, Alcohol, Drug Abuse and Mental Health Administration (1976). p. 218-22.
14. Lai YT, Wang TC, Chuang LJ, Chen MH, Wang PC. Epidemiology of vertigo: a national survey. Otolaryngol Head Neck Surg (2011) 145:110-6. doi:10.1177/0194599811400007.
15. Newman-Toker DE, Hsieh YH, Camargo CA, Pelletier AJ, Butchy GT, Edlow JA. Spectrum of dizziness visits to US emergency departments: cross-sectional analysis from a nationally representative sample. Mayo Clin Proc (2008) 83:765-75. doi:10.4065/83.7.765.
16. Gliklich R, Bertagna M. The Emerging Role of the Patient Registry. Drug Surveillance. London: Informa (2006).